| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 86 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 82 |
| 2 | TACROLIMUS OINTMENT 0.1% | 82 |
| 3 | MYCOPHENOLATE MOFETIL | 73 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 73 |
| 5 | VALGANCICLOVIR | 73 |
| 6 | VALGANCICLOVIR HYDROCHLORIDE | 73 |
| 7 | PREDNISONE | 62 |
| 8 | VALGANCICLOVIR HYDROCHLORIDE POWDER, | 60 |
| 9 | GANCICLOVIR SODIUM | 46 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN | 3 | 0.0062 |
| 1 | GANCICLOVIR SODIUM | 46 | 0.0043 |
| 2 | EMAPALUMAB-LZSG | 1 | 0.0042 |
| 3 | VALGANCICLOVIR | 73 | 0.0038 |
| 4 | CLEAR MINT, GEL TOOTHPASTE | 3 | 0.0027 |
| 5 | SODIUM FLUORIDE F18 | 3 | 0.0027 |
| 6 | SODIUM FLUORIDE F-18 | 3 | 0.0027 |
| 7 | LETERMOVIR | 4 | 0.0012 |
| 8 | BASILIXIMAB | 14 | 0.0012 |
| 9 | SODIUM FLUORIDE | 3 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interferon gamma Blocker [EPC] | 1 | 0.0042 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 84 | 0.0038 |
| 2 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 4 | 0.0012 |
| 3 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 14 | 0.0007 |
| 5 | Nucleoside Analog Antiviral [EPC] | 45 | 0.0005 |
| 6 | Complement 5a Receptor Antagonist [EPC] | 2 | 0.0003 |
| 7 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 8 | Antimalarial [EPC] | 2 | 0.0002 |
| 9 | Antiprotozoal [EPC] | 2 | 0.0002 |